2021 Q2 Form 10-Q Financial Statement
#000164033421001346 Filed on June 14, 2021
Income Statement
Concept | 2021 Q2 | 2020 Q2 | 2020 Q1 |
---|---|---|---|
Revenue | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Cost Of Revenue | |||
YoY Change | |||
Gross Profit | |||
YoY Change | |||
Gross Profit Margin | |||
Selling, General & Admin | $5.110K | $10.00K | $0.00 |
YoY Change | -48.9% | -100.0% | |
% of Gross Profit | |||
Research & Development | |||
YoY Change | |||
% of Gross Profit | |||
Depreciation & Amortization | |||
YoY Change | |||
% of Gross Profit | |||
Operating Expenses | $5.105K | $5.238K | $4.635K |
YoY Change | -2.54% | 15.4% | -19.08% |
Operating Profit | -$5.105K | -$5.238K | -$4.635K |
YoY Change | -2.54% | 15.4% | -19.08% |
Interest Expense | $1.448K | $1.217K | $1.197K |
YoY Change | 18.98% | ||
% of Operating Profit | |||
Other Income/Expense, Net | -$1.448K | -$1.217K | -$1.197K |
YoY Change | 18.98% | 33.59% | 42.5% |
Pretax Income | -$6.553K | -$6.455K | -$5.832K |
YoY Change | 1.52% | 18.44% | -11.21% |
Income Tax | $0.00 | $0.00 | $0.00 |
% Of Pretax Income | |||
Net Earnings | -$6.553K | -$6.455K | -$5.832K |
YoY Change | 1.52% | 18.44% | -11.21% |
Net Earnings / Revenue | |||
Basic Earnings Per Share | |||
Diluted Earnings Per Share | -$364.10 | $0.00 | $0.00 |
COMMON SHARES | |||
Basic Shares Outstanding | 39.21M shares | 17.99M shares | 17.99M shares |
Diluted Shares Outstanding |
Balance Sheet
Concept | 2021 Q2 | 2020 Q2 | 2020 Q1 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $160.00 | $0.00 | $0.00 |
YoY Change | |||
Cash & Equivalents | $162.00 | $3.174K | $4.155K |
Short-Term Investments | |||
Other Short-Term Assets | |||
YoY Change | |||
Inventory | |||
Prepaid Expenses | |||
Receivables | |||
Other Receivables | |||
Total Short-Term Assets | $162.00 | $3.174K | $4.155K |
YoY Change | -94.9% | ||
LONG-TERM ASSETS | |||
Property, Plant & Equipment | |||
YoY Change | |||
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | |||
YoY Change | |||
Total Long-Term Assets | $0.00 | -$3.174K | $0.00 |
YoY Change | -100.0% | ||
TOTAL ASSETS | |||
Total Short-Term Assets | $162.00 | $3.174K | $4.155K |
Total Long-Term Assets | $0.00 | -$3.174K | $0.00 |
Total Assets | $162.00 | $0.00 | $4.155K |
YoY Change | |||
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $10.79K | $10.00K | $10.00K |
YoY Change | 7.87% | 0.0% | |
Accrued Expenses | $15.35K | $10.00K | $10.00K |
YoY Change | 53.5% | 0.0% | |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $120.0K | $100.0K | $100.0K |
YoY Change | 19.95% | 25.0% | 42.86% |
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $146.1K | $120.0K | $112.6K |
YoY Change | 21.74% | 33.33% | 40.73% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Other Long-Term Liabilities | |||
YoY Change | |||
Total Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
YoY Change | |||
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $146.1K | $120.0K | $112.6K |
Total Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
Total Liabilities | $146.1K | $120.0K | $112.6K |
YoY Change | 21.74% | 33.33% | 40.73% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$293.5K | -$256.0K | |
YoY Change | |||
Common Stock | $201.4K | $147.5K | |
YoY Change | |||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | -$145.9K | -$114.9K | -$108.4K |
YoY Change | |||
Total Liabilities & Shareholders Equity | $162.00 | $0.00 | $4.155K |
YoY Change |
Cashflow Statement
Concept | 2021 Q2 | 2020 Q2 | 2020 Q1 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$6.553K | -$6.455K | -$5.832K |
YoY Change | 1.52% | 18.44% | -11.21% |
Depreciation, Depletion And Amortization | |||
YoY Change | |||
Cash From Operating Activities | -$16.22K | -$10.00K | $0.00 |
YoY Change | 62.2% | 0.0% | |
INVESTING ACTIVITIES | |||
Capital Expenditures | |||
YoY Change | |||
Acquisitions | |||
YoY Change | |||
Other Investing Activities | |||
YoY Change | |||
Cash From Investing Activities | |||
YoY Change | |||
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | 14.15K | 0.000 | 10.00K |
YoY Change | -100.0% | ||
NET CHANGE | |||
Cash From Operating Activities | -16.22K | -10.00K | 0.000 |
Cash From Investing Activities | |||
Cash From Financing Activities | 14.15K | 0.000 | 10.00K |
Net Change In Cash | -2.070K | -10.00K | 10.00K |
YoY Change | -79.3% | -200.0% | |
FREE CASH FLOW | |||
Cash From Operating Activities | -$16.22K | -$10.00K | $0.00 |
Capital Expenditures | |||
Free Cash Flow | |||
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2021Q2 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
39210000 | shares |
CY2021Q2 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
10787 | USD |
CY2020Q3 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
6482 | USD |
CY2021Q2 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
15345 | USD |
CY2021Q2 | us-gaap |
Due To Related Parties Current
DueToRelatedPartiesCurrent
|
119951 | USD |
CY2021Q2 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
146083 | USD |
CY2021Q2 | us-gaap |
Liabilities
Liabilities
|
146083 | USD |
CY2021Q2 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
50000000 | shares |
CY2021Q2 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2021Q2 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | USD |
CY2021Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
150000000 | shares |
CY2021Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2021Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
17990000 | shares |
CY2021Q2 | us-gaap |
Common Stock Value
CommonStockValue
|
1799 | USD |
CY2021Q2 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
145750 | USD |
CY2020Q3 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
145750 | USD |
CY2021Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-293470 | USD |
CY2021Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-145921 | USD |
CY2021Q2 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
162 | USD |
CY2021Q2 | us-gaap |
Professional Fees
ProfessionalFees
|
4753 | USD |
CY2020Q2 | us-gaap |
Professional Fees
ProfessionalFees
|
4307 | USD |
us-gaap |
Professional Fees
ProfessionalFees
|
19588 | USD | |
us-gaap |
Professional Fees
ProfessionalFees
|
19960 | USD | |
CY2021Q2 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
352 | USD |
CY2020Q2 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
931 | USD |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
937 | USD | |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
1444 | USD | |
CY2021Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
5105 | USD |
CY2020Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
5238 | USD |
CY2021Q2 | us-gaap |
Assets Current
AssetsCurrent
|
162 | USD |
CY2021Q2 | us-gaap |
Assets
Assets
|
162 | USD |
us-gaap |
Operating Expenses
OperatingExpenses
|
20525 | USD | |
us-gaap |
Operating Expenses
OperatingExpenses
|
21404 | USD | |
CY2021Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-5105 | USD |
CY2020Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-5238 | USD |
CY2020Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-121095 | USD |
CY2020Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-12132 | USD |
CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-133227 | USD |
CY2021Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-6141 | USD |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-20525 | USD | |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-21404 | USD | |
CY2021Q2 | us-gaap |
Interest Expense
InterestExpense
|
1448 | USD |
CY2020Q2 | us-gaap |
Interest Expense
InterestExpense
|
1217 | USD |
us-gaap |
Interest Expense
InterestExpense
|
4301 | USD | |
us-gaap |
Interest Expense
InterestExpense
|
3511 | USD | |
CY2021Q2 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-1448 | USD |
CY2020Q2 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-1217 | USD |
us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-4301 | USD | |
us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-3511 | USD | |
CY2021Q2 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
|
-6553 | USD |
CY2020Q2 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
|
-6455 | USD |
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
|
-24826 | USD | |
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
|
-24915 | USD | |
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | USD | |
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | USD | |
CY2021Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-6553 | USD |
CY2020Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-6455 | USD |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-24826 | USD | |
CY2021Q2 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.00 | |
CY2020Q2 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.00 | |
us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.00 | ||
us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.00 | ||
CY2021Q2 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
17990000 | shares |
CY2020Q2 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
17990000 | shares |
us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
17990000 | shares | |
us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
17990000 | shares | |
CY2021Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-139368 | USD |
CY2021Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-6553 | USD |
CY2021Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-145921 | USD |
CY2019Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-89971 | USD |
CY2019Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-102599 | USD |
CY2020Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-5832 | USD |
CY2020Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-108431 | USD |
CY2020Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-114886 | USD |
us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
4305 | USD | |
us-gaap |
Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
|
4301 | USD | |
us-gaap |
Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
|
3511 | USD | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-16220 | USD | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-18797 | USD | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-24826 | USD | |
us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
14150 | USD | |
us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
21300 | USD | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
14150 | USD | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
21300 | USD | |
us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-2070 | USD | |
us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
2503 | USD | |
CY2020Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
2232 | USD |
CY2019Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
671 | USD |
CY2021Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
162 | USD |
CY2020Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
3174 | USD |
us-gaap |
Interest Paid
InterestPaid
|
0 | USD | |
us-gaap |
Interest Paid
InterestPaid
|
0 | USD | |
us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
0 | USD | |
us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
0 | USD | |
pnht |
Changes In Control Of Registrantpolicytextblock
ChangesInControlOfRegistrantpolicytextblock
|
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">On April 26, 2021, the board of director of the Company approved a security purchase agreement with T. Benjamin Jennings or assignees to sell and issue 21,220,000 shares of the common stock at $201,335 in cash. The issuance of 21,220,000 shares of common stock to T. Benjamin Jennings pursuant to the security purchase agreement representing around 54% of the then issued and outstanding shares of the Company at closing date. The Company received the consideration in full and issued the shares on May 12, 2021.</p> | ||
us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. The estimates and judgments will also affect the reported amounts for certain expenses during the reporting period. Actual results could differ from these good faith estimates and judgments.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">A novel strain of coronavirus (COVID-19) was first identified in December 2019, and subsequently declared a global pandemic by the World Health Organization on March 11, 2020. As a result of the outbreak, many companies have experienced disruptions in their operations and in markets served. The Company considered the impact of COVID-19 on the assumptions and estimates used and determined that there were no material adverse impacts on the Company’s results of operations and financial position at April 30, 2021. The full extent of the future impacts of COVID-19 on the Company’s operations is uncertain. A prolonged outbreak could have a material adverse impact on financial results and business operations of the Company, including the timing and ability of the Company to develop its business plan.</p> | ||
us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
14150 | USD | |
CY2021Q2 | us-gaap |
Due To Related Parties Current
DueToRelatedPartiesCurrent
|
119951 | USD |
us-gaap |
Interest Expense
InterestExpense
|
4301 | USD | |
us-gaap |
Interest Expense
InterestExpense
|
3511 | USD |